Consilio Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
787
+11
+1% +$3.77K 0.07% 86
2026
Q1
$273K Buy
776
+18
+2% +$6.42K 0.08% 74
2025
Q4
$248K Buy
758
+3
+0.4% +$952 0.07% 84
2025
Q3
$213K Sell
755
-46
-6% -$13.3K 0.07% 92
2025
Q2
$222K Buy
801
+70
+10% +$19.8K 0.08% 81
2025
Q1
$228K Buy
+731
New +$216K 0.1% 62
2024
Q4
Sell
-723
Closed -$233K 73
2024
Q3
$233K Buy
723
+28
+4% +$9.16K 0.1% 60
2024
Q2
$217K Buy
+695
New +$204K 0.1% 59

Other funds holding AMGN

Consilio Wealth Advisors's AMGN Position: Q2 2026 in Review

Consilio Wealth Advisors increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $3.77K and bringing the position to 787 shares worth $285K. The position accounts for 0.07% of the portfolio, ranked #86.

Consilio Wealth Advisors first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Consilio Wealth Advisors held 787 shares of Amgen worth $285K as of Q2 2026.
  • Consilio Wealth Advisors bought 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.07% of Consilio Wealth Advisors's portfolio in Q2 2026, its #86 holding.
  • Consilio Wealth Advisors first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Consilio Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.